Cbl-b and itch: key regulators of peripheral T-cell tolerance
- PMID: 20395198
- PMCID: PMC2856114
- DOI: 10.1158/0008-5472.CAN-09-4076
Cbl-b and itch: key regulators of peripheral T-cell tolerance
Abstract
E3 ligases Cbl-b and Itch have emerged as dominant "tolerogenic" regulators of T cells because their deficiency results in severe autoimmune diseases. Cbl-b and Itch ligase activity regulate T-cell anergy and development of Foxp3+ regulatory T cells (Treg) in the periphery by modulating key components of T-cell receptor (TCR) and transforming growth factor-beta (TGF-beta) signaling. Manipulation of Cbl-b and Itch activities may provide unique opportunities to develop future therapies for immune disorders such as autoimmunity and cancer.
Keywords: Foxp3; Tolerance; Tregs; Ubiquitination; tumor Immunity.
(c) 2010 AACR.
Figures

References
-
- Walker LS, Abbas AK. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol. 2002;2:11–9. - PubMed
-
- Venuprasad K, Yang C, Shao Y, et al. Immune regulation by ubiquitin conjugation. Adv Exp Med Biol. 2006;584:207–17. - PubMed
-
- Gao M, Karin M. Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli. Mol Cell. 2005;19:581–93. - PubMed
-
- Chiang YJ, Kole HK, Brown K, et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature. 2000;403:216–20. - PubMed
-
- Bachmaier K, Krawczyk C, Kozieradzki I, et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature. 2000;403:211–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous